Coronavirus tally: FDA approves Novavax vaccine at time when uptake of shots and boosters is low
[ad_1] U.S. health regulators authorized the use of Novavax Inc.’s NVAX, +0.27% COVID-19 vaccine, providing a new option that works differently than the two leading vaccines, but at a time…